SCHEMBL20138231

SCHEMBL20138231

Cc1nc2ccc(C#N)cn2c1CN1C(=O)[C@@H](C)Oc2c(F)cc(-c3cc(F)cc(S(C)(=N)=O)c3)cc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20138154 0.92 DCK (0.31)
SCHEMBL20138009 0.85 NTRK2 (0.30)
SCHEMBL20138041 0.84 DCK (0.33)
SCHEMBL20138148 0.84 NR1H2 (0.30)
SCHEMBL20138004 0.84 NTRK2 (0.30)
SCHEMBL20138212 0.82 PRNP (0.33)
SCHEMBL20138049 0.81 MEN1 (0.32)
SCHEMBL20138044 0.80
SCHEMBL20138259 0.80 SLC2A1 (0.31)
SCHEMBL20138080 0.79 NR1H2 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10287299-B2 Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity UCB BIOPHARMA SPRL (BE) 2019-05-14 US disclosed
US-20180134728-A1 Benzoxazinone Derivatives and Analogues Thereof as Modulators of TNF Activity UCB S.A. (BE) 2018-05-17 US disclosed